Triomics

TriomicsTriomics
Triomics

Triomics

AI-powered platform for drug discovery and development, accelerating research with advanced analytics.

Website
DR 462021Active67Cambridge, United States
Rate
Advertise here

About

Triomics is a biotechnology company leveraging artificial intelligence to accelerate drug discovery and development. Their platform integrates multi-omics data with advanced computational methods to identify novel therapeutic targets and predict drug efficacy, aiming to significantly reduce the time and cost of bringing new medicines to market.

Technology stack

detected 2026-07-08
CDN
Emailunknown
Stack
HEADCOUNT
67
DOMAIN RATING
46
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Triomics do?

Triomics is a biotechnology company leveraging artificial intelligence to accelerate drug discovery and development. Their platform integrates multi-omics data with advanced computational methods to identify novel therapeutic targets and predict drug efficacy, aiming to significantly reduce the time and cost of bringing new medicines to market.

How much funding has Triomics raised?

Triomics has raised a total of $22M in funding. The most recent round on record is Series B.

Where is Triomics headquartered?

Triomics is headquartered in Cambridge, United States.

When was Triomics founded?

Triomics was founded in 2021.

What industry does Triomics operate in?

Triomics operates in Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design, Genomics, Foundation Model.

How many employees does Triomics have?

Triomics has approximately 67 people on record.

What is Triomics's revenue?

StartupHub estimates Triomics's annual revenue at $7.6M (range $3.9M to $30.4M, 64% confidence), based on comparable companies in the sector.

What is Triomics's valuation?

StartupHub estimates Triomics's effective valuation at $91.0M (range $55.0M to $132.0M, 12% confidence), based on comparable companies in the sector.